
The N-Acetyl Semax Amidate Analysis is a targeted laboratory test designed to confirm the identity, determine the amount, and assess the peptide purity of N-Acetyl Semax Amidate in lyophilised vials and raw active pharmaceutical ingredient (API) powders.
For lyophilised samples, results are reported in milligrams per vial together with peptide purity. Raw API powders can be evaluated using purity in % (m/m) together with peptide purity.
N-Acetyl Semax Amidate is a modified form of Semax, a synthetic heptapeptide related to the ACTH(4–10) fragment and studied primarily for its neuroactive and neuroprotective properties.
This form is used primarily as a research compound, and scientific data specifically focused on N-Acetyl Semax Amidate remain limited.
Important Notice
- This analysis is specifically intended for N-Acetyl Semax Amidate. Before ordering, please make sure that the sample contains this specific form and not another version of Semax.
- The analysis does not automatically screen the sample for standard Semax, other Semax variants, related peptides, degradation products, contaminants, or undeclared substances.
- For lyophilised samples, one whole unopened vial containing lyophilisate is required.
- Raw API powder should be supplied as at least 30 mg in a sealed glass vial to protect the sample from moisture.
- The alternative result format for raw API powders includes both purity in % (m/m) and peptide purity.
The following optional laboratory services are available:
